Last reviewed · How we verify
NCT05716399
Effect of Acupoint Electrical Stimulation on Incidence of Hypotension After Spinal Anesthesia
NA trial testing Transcutaneous electric stimulation pretreatment in Anesthesia in 111 participants. Status unknown.
20 December 2023
Quick facts
| Lead sponsor | Shanghai Tongji Hospital, Tongji University School of Medicine |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 111 |
| Start date | 20 February 2023 |
| Primary completion | 20 December 2023 |
| Estimated completion | 30 December 2023 |
Drugs / interventions tested
- Transcutaneous electric stimulation pretreatment
- Transcutaneous acupoint electrical stimulation treatment
- Transcutaneous acupoint pseudo electric stimulation
Conditions studied
- Anesthesia — all drugs for Anesthesia →
Sponsor
Shanghai Tongji Hospital, Tongji University School of Medicine
Who can join
Adults 65 to 90, any sex, with Anesthesia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is intended to include elderly patients who are selected to undergo lower limb and pelvic orthopedic surgery under spinal anesthesia. Through prospective, randomized and controlled clinical trials, the investigators will observe the effect of this treatment on the incidence of hypotension in elderly patients after spinal anesthesia through TEAS points Neiguan and Quchi before or during surgery, and further explore its related mechanisms.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05716399
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Anesthesia
Currently open trials in the same condition.
- NCT07294092 — Ketamine and Propofol NeuroImaging · EARLY_PHASE1 · recruiting
- NCT07290205 — Remimazolam NeuroImaging · EARLY_PHASE1 · recruiting
- NCT07465185 — Intrathecal Bupivacaine With or Without Dexmetomidine for Cesserian Delivery · Phase 2 · recruiting
- NCT07269808 — Sedation During Endoscopy Using Remimazolam: Efficacy in a Novel Exploration · Phase 3 · recruiting
- NCT07443254 — Prospective IR-led Sedation Feasibility · Phase 1, PHASE2 · recruiting
Other Shanghai Tongji Hospital, Tongji University School of Medicine trials
Trials by the same sponsor.
- NCT07384390 — TH-CAR-027 for Grade 4 Gliomas · EARLY_PHASE1 · not yet recruiting
- NCT07043218 — A Clinical Study Exploring Universal CAR-T Cell in Patients With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia · Phase 1 · not yet recruiting
- NCT07064109 — Multi-omics Characterization and Model Construction of Colchicine Anti-inflammatory Therapy Efficacy in ACS Patients · NA · recruiting
- NCT06951425 — An Exploratory Clinical Study of the Efficiency and Safety of TH027 in the Treatment of Relapsed/Refractory Solid Tumors · EARLY_PHASE1 · not yet recruiting
- NCT06987916 — Efficacy and Safety Evaluation of U01(ssCART-19) in B-Cell Lymphoma · Phase 1, PHASE2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05716399 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shanghai Tongji Hospital, Tongji University School of Medicine
- Last refreshed: 8 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05716399.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing